Presentation TCT 2016 From Severe LV Dysfunction Without Heart Failure to Killip Class III and IV: Who Needs Mechanical Hemodynamic Support During Primary PCI? Presenter: Cindy L. Grines, Holger Thiele, Vladimir Dzavik October 31, 2016
Presentation TCT 2016 STICH and STICHES Critique: Pros and Cons Presenter: Sunil V. Rao, Harvey D. White, James E. Udelson October 31, 2016
Presentation TCT 2016 Case Presentation: A Patient Presenting With Cardiac Arrest Presenter: Cindy L. Grines, Holger Thiele, Michael Mooney October 31, 2016
Presentation TCT 2016 Trial #4 - The Essentials of ... STICH and STICHES - Ten-Year Follow-up Presenter: Sunil V. Rao, Harvey D. White, Robert A. Guyton October 31, 2016
Presentation TCT 2016 Hypothermia and Cardiac Arrest: New Data on Patient Selection, Timing and Cooling Protocols Presenter: Cindy L. Grines, Holger Thiele, David Erlinge October 31, 2016
Presentation TCT 2016 LEADERS FREE: Pros and Cons Presenter: Sunil V. Rao, Harvey D. White, Donald Cutlip October 31, 2016
Presentation TCT 2016 Out-of-Hospital Cardiac Arrest: Who Benefits By an Immediate Invasive Strategy? Presenter: Cindy L. Grines, Holger Thiele, Christian M. Spaulding October 31, 2016
Presentation TCT 2016 Trial #3 - The Essentials of ... the LEADERS FREE trial Presenter: Sunil V. Rao, Harvey D. White, Philip M. Urban October 31, 2016
Presentation TCT 2016 MATRIX Critique: Pros and Cons Presenter: Sunil V. Rao, Harvey D. White, Frederick Feit October 31, 2016
Presentation TCT 2016 Acute Cardiogenic Shock Treatment Algorithm 3: The Case for First-line Use of ECMO Presenter: Simon R. Dixon, Holger Thiele, A. Reshad Garan October 31, 2016
Presentation TCT 2016 Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS Presenter: Sunil V. Rao, Harvey D. White, Salvatore Brugaletta October 31, 2016
Presentation TCT 2016 Acute Cardiogenic Shock Treatment Algorithm 2: The Case for First-line Use of Impella Presenter: Simon R. Dixon, Holger Thiele, Jerry D Estep October 31, 2016
Presentation TCT 2016 Acute Cardiogenic Shock Treatment Algorithm 1: The Case for First-line Use of IABP Presenter: Simon R. Dixon, Holger Thiele, Susan M Joseph October 31, 2016
Presentation TCT 2016 ABSORB III Critique: Pros and Cons Presenter: Sunil V. Rao, Harvey D. White, Ron Waksman October 31, 2016
Presentation TCT 2016 Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease Presenter: Sunil V. Rao, Harvey D. White, Stephen G. Ellis October 31, 2016
Presentation TCT 2016 Acute Cardiogenic Shock: Pathophysiology and Representative Case Presentation Presenter: Simon R. Dixon, Holger Thiele, Ulrich P. Jorde October 31, 2016
Presentation TCT 2016 TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation Presenter: Michael J. Cowley, Franz-Josef Neumann, Shunsuke Kubo October 31, 2016
Presentation TCT 2016 TCT 51: In-Hospital and One-Month Outcomes of 983 Patients Implanted With Bioresorbable Vascular Scaffolds for Acute Coronary Syndroms; Subgroup of the Prospective, All Comers, Controlled, Multicenter, FRANCE ABSORB Registry Presenter: Michael J. Cowley, Franz-Josef Neumann, Joel Sainsous October 31, 2016
Presentation TCT 2016 A Prospective, Randomized Trial of Impella vs Intra-aortic Balloon Counterpulsation in Patients with Cardiogenic Shock Presenter: Thomas F. Luscher, Patrick W. Serruys, Jose P.S. Henriques October 31, 2016
Presentation TCT 2016 TCT 50: Impact of a Bifurcation Culprit Lesion in ST Elevation Myocardial Infarction: Procedural Success, Clinical Outcome, and Five-Year Follow-up Presenter: Michael J. Cowley, Franz-Josef Neumann, Pablo Salinas October 31, 2016